Ian Tannock

13PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyData and information privacyPharmacogenomicsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 24, 2026
Value, Access, and High-Quality Medical Oncology Care: Can We Have It All?

|Apr 15, 2026
Mapping Radiotherapy Resources for Prostate Cancer Trials in Nigeria: A STAMPEDE 2-Site Survey.

|Oct 13, 2025
Conflict of Interest: Moving From Disclosure to Avoidance.

Ian F Tannock, Saroj Niraula

|Apr 14, 2025
Why We Do Not Recommend That Women With Breast Cancer Receive Adjuvant Treatment With a CDK4/6 Inhibitor.

Ian F Tannock, Qamar J Khan, Tito Fojo

|Jan 31, 2025
Comparison of standard-dose and reduced-dose treatment of metastatic prostate cancer with enzalutamide, apalutamide or darolutamide: a rapid review.

Hannah Louise Bromley, Mohini Varughese, Duncan C Gilbert

|Jan 31, 2025
Pharmacological class effects of anticancer drugs: opportunities for decreasing healthcare spending.

Daniel A Goldstein, Leonard B Saltz, Gregory R Pond

Pageof 3

Frequent Collaborators

3 joint publications

Bishal Gyawali

2 joint publications

Mark J Ratain

2 joint publications

Daniel A Goldstein

2 joint publications

Allen S Lichter